Work

Abstract LB-202: Phase 1 dose escalation trial of the novel vascular disrupting agent NPI-2358

Year: 2008

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2008-lb-202

Authors: Monica Mita, Matthew A Spear, Lorrin K Yee, K P Papadopoulos, Elisabeth Heath, Ofelia Romero, G Kenneth Lloyd, Gillian Cropp, Alain Mita, Patricia LoRusso

Institutions: Northwest Medical Specialties, The Barbara Ann Karmanos Cancer Institute

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2943973648

Cites:

Cited by: 1

Related to: 10